Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD45 expression on Rhesus macaque peripheral blood leukocytes. Rhesus macaque whole blood was stained with PE-Cy™7 Mouse anti-NHP CD45 antibody (Cat. No. 561294; Right Panel) or with a PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; Left Panel). The erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No. 555899). Two parameter flow cytometric dot blots showing the correlated expression of CD45 (or Ig Isotype control staining) versus side-scattered light signals were derived from events with the forward light scatter signals of viable leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45 expression on Rhesus macaque peripheral blood leukocytes. Rhesus macaque whole blood was stained with PE-Cy™7 Mouse anti-NHP CD45 antibody (Cat. No. 561294; Right Panel) or with a PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; Left Panel). The erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No. 555899). Two parameter flow cytometric dot blots showing the correlated expression of CD45 (or Ig Isotype control staining) versus side-scattered light signals were derived from events with the forward light scatter signals of viable leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45 expression on Rhesus macaque peripheral blood leukocytes. Rhesus macaque whole blood was stained with PE-Cy™7 Mouse anti-NHP CD45 antibody (Cat. No. 561294; Right Panel) or with a PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; Left Panel). The erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No. 555899). Two parameter flow cytometric dot blots showing the correlated expression of CD45 (or Ig Isotype control staining) versus side-scattered light signals were derived from events with the forward light scatter signals of viable leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45 expression on Rhesus macaque peripheral blood leukocytes. Rhesus macaque whole blood was stained with PE-Cy™7 Mouse anti-NHP CD45 antibody (Cat. No. 561294; Right Panel) or with a PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; Left Panel). The erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No. 555899). Two parameter flow cytometric dot blots showing the correlated expression of CD45 (or Ig Isotype control staining) versus side-scattered light signals were derived from events with the forward light scatter signals of viable leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45 expression on Rhesus macaque peripheral blood leukocytes. Rhesus macaque whole blood was stained with PE-Cy™7 Mouse anti-NHP CD45 antibody (Cat. No. 561294; Right Panel) or with a PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; Left Panel). The erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No. 555899). Two parameter flow cytometric dot blots showing the correlated expression of CD45 (or Ig Isotype control staining) versus side-scattered light signals were derived from events with the forward light scatter signals of viable leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45 expression on Rhesus macaque peripheral blood leukocytes. Rhesus macaque whole blood was stained with PE-Cy™7 Mouse anti-NHP CD45 antibody (Cat. No. 561294; Right Panel) or with a PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; Left Panel). The erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No. 555899). Two parameter flow cytometric dot blots showing the correlated expression of CD45 (or Ig Isotype control staining) versus side-scattered light signals were derived from events with the forward light scatter signals of viable leukocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
D058-1283 is a CD45 monoclonal antibody specific for non-human primate leucocytes. It was developed using Rhesus peripheral whole blood as the immunogen. It does not cross-react with human leucocytes. This antibody reacts with baboon, Rhesus and Cynomolgus Macaque leucocytes in a similar pattern to CD45 binding to leukocyte common antigen (LCA) on human cells. Immunophenotypic analysis shows that D058-1283 binds to lymphocytes, monocytes and granulocytes of non-human primate blood samples. This antibody is able to block the binding of monoclonal antibody TÜ116; a reported anti-human CD45 antibody that cross-reacts with nonhuman primate leucocytes. In Western blot analysis, the D058-1283 antibody identifies a 180-200 kDa band.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.